Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
STEVEN GIRGENTI Insider Profile
4 Followers
STEVEN GIRGENTI, Director at Vycor Medical, holds 1.07M shares in bioAffinity Technologies, Inc. (Ticker: BIAF), holds 625.45K shares in Vycor Medical (Ticker: VYCO).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
-20.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that STEVEN GIRGENTI holds in companies
Most Profitable Insider Trade
The most profitable trade made by STEVEN GIRGENTI
STEVEN GIRGENTI's Trading History
Vycor Medical
Apr 08, 2021
Director
Informative Buy
6.93
$43.16K
bioAffinity Technologies, Inc.
Jul 02, 2024
EC, Director
Uninformative Buy
―
$1.07M
List of latest transactions for each holding click on a transaction to see STEVEN GIRGENTI's performance on stock
You May Also Like
STEVEN GIRGENTI insider profile FAQ
What is the percentage of profitable transactions made by STEVEN GIRGENTI?
The percentage of profitable transactions made by STEVEN GIRGENTI is 50%.
What is the average return per transaction made by STEVEN GIRGENTI?
The average return per transaction made by STEVEN GIRGENTI is -20.00%.
What stocks does STEVEN GIRGENTI hold?
STEVEN GIRGENTI holds: VYCO, BIAF stocks.
What was STEVEN GIRGENTI’s latest transaction?
STEVEN GIRGENTI latest transaction was an Uninformative Buy of ―.
What was STEVEN GIRGENTI's most profitable transaction?
STEVEN GIRGENTI’s most profitable transaction was an Informative Buy of VYCO stock on April 8, 2021. The return on the trade was 3.40%.
What is STEVEN GIRGENTI's role in Vycor Medical?
STEVEN GIRGENTI's role in Vycor Medical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.